Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

St. John's Wort constituents modulate P-glycoprotein transport activity at the blood-brain barrier.

Ott M, Huls M, Cornelius MG, Fricker G.

Pharm Res. 2010 May;27(5):811-22. doi: 10.1007/s11095-010-0074-1. Epub 2010 Mar 13.

PMID:
20229133
2.

MDR- and CYP3A4-mediated drug-herbal interactions.

Pal D, Mitra AK.

Life Sci. 2006 Mar 27;78(18):2131-45. Epub 2006 Jan 25. Review.

PMID:
16442130
3.

Functional expression and localization of P-glycoprotein at the blood brain barrier.

Bendayan R, Lee G, Bendayan M.

Microsc Res Tech. 2002 Jun 1;57(5):365-80. Review.

PMID:
12112443
4.

Mechanism of action of St John's wort in depression : what is known?

Butterweck V.

CNS Drugs. 2003;17(8):539-62. Review.

PMID:
12775192
5.

Pharmacokinetic interactions of drugs with St John's wort.

Zhou S, Chan E, Pan SQ, Huang M, Lee EJ.

J Psychopharmacol. 2004 Jun;18(2):262-76. Review.

PMID:
15260917
6.

Herbal modulation of P-glycoprotein.

Zhou S, Lim LY, Chowbay B.

Drug Metab Rev. 2004 Feb;36(1):57-104. Review.

PMID:
15072439
7.

An update on clinical drug interactions with the herbal antidepressant St. John's wort.

Zhou SF, Lai X.

Curr Drug Metab. 2008 Jun;9(5):394-409. Review.

PMID:
18537576
8.

Molecular mechanisms underlying St. John's wort drug interactions.

Kober M, Pohl K, Efferth T.

Curr Drug Metab. 2008 Dec;9(10):1027-37. Review.

PMID:
19075619
9.

Modulation of p-glycoprotein transport function at the blood-brain barrier.

Bauer B, Hartz AM, Fricker G, Miller DS.

Exp Biol Med (Maywood). 2005 Feb;230(2):118-27. Review.

PMID:
15673560
10.

St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.

Barnes J, Anderson LA, Phillipson JD.

J Pharm Pharmacol. 2001 May;53(5):583-600. Review.

PMID:
11370698
11.

St John's Wort supplements endanger the success of organ transplantation.

Ernst E.

Arch Surg. 2002 Mar;137(3):316-9. Review.

PMID:
11888457
12.

Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain.

Golden PL, Pardridge WM.

Cell Mol Neurobiol. 2000 Apr;20(2):165-81. Review.

PMID:
10696508
13.

Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.

Miller DS, Bauer B, Hartz AM.

Pharmacol Rev. 2008 Jun;60(2):196-209. doi: 10.1124/pr.107.07109. Epub 2008 Jun 17. Review.

14.

The role of p-glycoprotein in psychiatric disorders: a reliable guard of the brain?

De Klerk OL, Bosker FJ, Luurtsema G, Nolte IM, Dierckx R, Den Boer JA, Potschka H.

Cent Nerv Syst Agents Med Chem. 2011 Sep 1;11(3):197-209. Review.

PMID:
21919870
15.

P-glycoprotein at the blood-brain barrier and analysis of drug transport with positron-emission tomography.

Hendrikse NH, Bart J, de Vries EG, Groen HJ, van der Graaf WT, Vaalburg W.

J Clin Pharmacol. 2001 Jul;Suppl:48S-54S. Review. No abstract available.

PMID:
11452728

Supplemental Content

Support Center